BioSpace News Archive

Business

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

Codexis, Inc., a leading enzyme engineering company, announced the appointment of Carole Cobb, MBA, to the Company’s Strategic Advisory Board.

April 11, 2024
·
7 min read
LSL Pharma Group Announces the Upsizing of Its Private Placement From $3.5 Million to $7.5 Million

LSL PHARMA GROUP INC., a Canadian integrated pharmaceutical company, announced the upsizing of its previously communicated non-brokered private placement financing of Units to maximum gross proceeds of $7.5 million .

April 11, 2024
·
4 min read
Drug Development

Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, announced the publication of preclinical data supporting the therapeutic potential of fosgonimeton in Alzheimer’s disease.

April 11, 2024
·
6 min read
Deals

Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

Eliem Therapeutics, Inc. and Tenet Medicines, Inc., a development-stage private biotechnology company, announced that the companies have entered into a definitive acquisition agreement whereby Eliem has agreed to acquire Tenet.

April 11, 2024
·
14 min read
Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research’s Pitch, Deep Dive and Q&A Webinar on April 16th, 2024

Algernon Pharmaceuticals Inc., is pleased to invite investors and other interested parties to participate in an upcoming special CEO interview and Q & A session on April 16th, 2024, at 4 PM ET / 1 PM PT, hosted by Market Radius Research.

April 11, 2024
·
4 min read
STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital

STERIS plc announced that the Company has entered into a definitive agreement to divest its Dental segment to Peak Rock Capital, a leading middle-market private investment firm, for $787.5 million.

April 11, 2024
·
9 min read
Deals

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics

Century Therapeutics announced plans to expand clinical development for its lead program, CNTY-101, a CD19-targeting iNK cell therapy, into additional autoimmune disease indications.

April 11, 2024
·
13 min read
Business

Labcorp Declares Quarterly Dividend - April 11, 2024

Labcorp, a global leader of innovative and comprehensive laboratory services, announced that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.

April 11, 2024
·
1 min read
Bio NC

ProPharma Announces Changes to Its Executive Leadership Team

ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners is pleased to announce that it has welcomed Kirk Wroblewski as its new Chief Information Officer and Andrew Shaw as General Counsel.

April 11, 2024
·
4 min read
BioMidwest

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity

Lipocine Inc., a biopharmaceutical company, announced results from a Phase 2 clinical trial which includes LPCN 2401, an oral proprietary combination of anabolic androgen receptor agonist and α-tocopherol, an antioxidant.

April 11, 2024
·
11 min read